Positron emission tomography for staging and management of malignant melanoma.
about
Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciencesAnal melanomaNon-invasive molecular imaging of prostate cancer lymph node metastasis.Melanin-targeted preclinical PET imaging of melanoma metastasis.Current concepts of metastasis in melanoma.Surgical treatment of melanoma.A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomyDevelopment of 18F-labeled picolinamide probes for PET imaging of malignant melanoma.PET scanning in plastic and reconstructive surgery.No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma.Primary giant aggressive amelanotic duodenal melanoma.(18)F-FDG PET-CT for Staging of Conjunctival Melanoma.Pancreatic resection for metastatic melanoma.PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates.Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients.Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.[Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
P2860
Q24795884-B9C589D1-7F79-468C-84E7-D6FEEBD8A512Q30437650-BCE1E427-92EA-474F-9FDB-BAB3A39A3006Q33557567-37B7D097-B983-4E07-AE62-84F274987B65Q34430797-9468B673-160C-4051-A345-EDD68005A9F6Q34610427-E79EC1F9-5202-4DD4-87B3-3712C1632E97Q35188550-D0B4DD43-048C-4E27-ABBF-E96D916B4B1BQ36430749-AF096BE0-7C48-4FF6-B014-96DC8A896267Q36650623-FBF1F9B8-4EBB-4635-AE0B-070E5E63E04CQ37973634-1BF1E7C5-2EC3-4784-81B5-F1AA26EEB219Q38129831-39CCB946-C13C-4E8E-9A56-3F27DA468D33Q39277591-F5038FD5-4155-4C71-82F8-56391937B30DQ39364421-775DD887-CAA4-45FA-BFC5-886B881ABD78Q42571550-E7E86213-A98F-4E8E-9BDB-B1866FCE6F14Q43082545-0C0F0D52-E5FA-4EF2-A678-B1B3163465BEQ45166889-1D93BB90-44B8-4EFA-A981-53E1C91BE7C2Q45222872-74373A24-4CBA-4A9D-98BB-4E0575A8B917Q53468706-EC3A0A94-34B7-4EBD-9AA2-2B80B2523597Q53637858-C3A44DAE-68A9-4650-A673-04178D56D52F
P2860
Positron emission tomography for staging and management of malignant melanoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Positron emission tomography for staging and management of malignant melanoma.
@ast
Positron emission tomography for staging and management of malignant melanoma.
@en
Positron emission tomography for staging and management of malignant melanoma.
@nl
type
label
Positron emission tomography for staging and management of malignant melanoma.
@ast
Positron emission tomography for staging and management of malignant melanoma.
@en
Positron emission tomography for staging and management of malignant melanoma.
@nl
prefLabel
Positron emission tomography for staging and management of malignant melanoma.
@ast
Positron emission tomography for staging and management of malignant melanoma.
@en
Positron emission tomography for staging and management of malignant melanoma.
@nl
P2093
P2860
P1476
Positron emission tomography for staging and management of malignant melanoma.
@en
P2093
O'Higgins NJ
Prichard RS
P2860
P304
P356
10.1046/J.0007-1323.2002.02059.X
P407
P577
2002-04-01T00:00:00Z